Not applicableStudy completedNCT03060642What this trial is testingThe Microenvironment in Barrett's EsophagusWho this might be right forBarrett EsophagusEsophageal Adenocarcinoma Columbia University 155
Testing effectiveness (Phase 2)Study completedNCT02971956What this trial is testingPembrolizumab in Refractory Advanced Esophageal CancerWho this might be right forEsophageal CancerSquamous Cell Esophagus CancerAdenocarcinoma Esophagus Dana-Farber Cancer Institute 49
Testing effectiveness (Phase 2)Study completedNCT00040859What this trial is testingOxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach CancerWho this might be right forEsophageal CancerGastric Cancer Alliance for Clinical Trials in Oncology 48
Testing effectiveness (Phase 2)UnknownNCT00964080What this trial is testingStudy of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma Mebiopharm Co., Ltd 62
Not applicableNot Yet RecruitingNCT07517211What this trial is testingA Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO StudyWho this might be right forClinical Stage I Esophageal Adenocarcinoma AJCC v8Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage I Gastric Cancer AJCC v8+9 more Jonsson Comprehensive Cancer Center 72
Early research (Phase 1)Active Not RecruitingNCT03132922What this trial is testingMAGE-A4ᶜ¹º³²T for Multi-TumorWho this might be right forUrinary Bladder CancerMelanomaHead and Neck Cancer+7 more USWM CT, LLC 71
Early research (Phase 1)Study completedNCT03329950What this trial is testingCDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesWho this might be right forMelanomaNon-small Cell Lung CancerBreast Cancer+23 more Celldex Therapeutics 132
Not applicableStudy completedNCT00253708What this trial is testingMassage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic CancerWho this might be right forCancer Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT00258323What this trial is testingRadiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction CancerWho this might be right forEsophageal Cancer Case Comprehensive Cancer Center 80
Testing effectiveness (Phase 2)Ended earlyNCT00258297What this trial is testingGefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By SurgeryWho this might be right forEsophageal Cancer University of Rochester 30
Not applicableWithdrawnNCT00499291What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsWho this might be right forCancer Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT05394740What this trial is testingClinical Study of Regorafenib and Nivolumab Plus ChemotherapyWho this might be right forGastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma National Cancer Center Hospital East 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07233850What this trial is testingA Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal CancersWho this might be right forGastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more Shenyang Sunshine Pharmaceutical Co., LTD. 300
Not applicableLooking for participantsNCT05276791What this trial is testingEMR Versus ESD for Barrett's NeoplasiaWho this might be right forBarretts Esophagus With DysplasiaBarrett AdenocarcinomaEsophageal Cancer St. Antonius Hospital 331
Large-scale testing (Phase 3)Study completedNCT00052910What this trial is testingChemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal CancerWho this might be right forEsophageal CancerGastric Cancer Alliance for Clinical Trials in Oncology 546
Testing effectiveness (Phase 2)Looking for participantsNCT06265285What this trial is testingComparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramWho this might be right forAdvanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more Mayo Clinic 50
Large-scale testing (Phase 3)Study completedNCT04210115What this trial is testingStudy of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)Who this might be right forEsophageal Squamous Cell Carcinoma (ESCC)Gastroesophageal Junction Carcinoma (GEJC)Esophageal Adenocarcinoma (EAC) Merck Sharp & Dohme LLC 703
Large-scale testing (Phase 3)Study completedNCT04879368What this trial is testingRegoNivo vs Standard of Care Chemotherapy in AGOCWho this might be right forGastro-Oesophageal Cancer Australasian Gastro-Intestinal Trials Group 462
Testing effectiveness (Phase 2)Active Not RecruitingNCT04430738What this trial is testingTucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal CancersWho this might be right forColorectal CarcinomaGastric AdenocarcinomaGEJ Adenocarcinoma+3 more Seagen, a wholly owned subsidiary of Pfizer 40
Not applicableStudy completedNCT06277921What this trial is testingMorbidity and Mortality After Esophageal and Esophagogastric Junction Cancer SurgeryWho this might be right forEsophageal CancerOesophageal CancerSiewert Type I Adenocarcinoma of Esophagogastric Junction+1 more P. Herzen Moscow Oncology Research Institute 230